Overview
Firoj Mamun-Al practices practicing medicine in Dhaka, Bangladesh.
Their clinical expertise encompasses Insomnia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Tetanus.
They are actively involved in clinical research, co-authoring 67 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Firoj Mamun-Al
Is Firoj Mamun-Al a top-rated expert for Insomnia?
MediFind is an objective health platform that identifies experts based on real-world data. Firoj Mamun-Al is classified as an Experienced expert for Insomnia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Firoj Mamun-Al participate in research or clinical trials?
Yes. Firoj Mamun-Al has published 67 articles and abstracts on conditions like Insomnia. You can view a list of Firoj Mamun-Al's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Mamun-Al isExperienced. Learn about COVID-19.
- InsomniaMamun-Al isExperienced. Learn about Insomnia.
- Postpartum DepressionMamun-Al isExperienced. Learn about Postpartum Depression.
- Severe Acute Respiratory Syndrome (SARS)
- TetanusMamun-Al isExperienced. Learn about Tetanus.